Comparative effectiveness of triple therapy versus guideline recommended dual therapy (ICS/LABA and LAMA/LABA) alternatives in patients with COPD

The study will evaluate the comparative effectiveness of different (guideline-recommended) treatment options as prescribed in a UK routine care population with confirmed COPD, eligible for triple therapy, specifically:

(A) LAMA versus ICS/LAMA/LABA
(B) ICS/LABA versus ICS/LAMA/LABA
(C) LAMA/LABA versus ICS/LAMA/LABA

Lead Investigator:
Alberto Papi: Professor of Respiratory Medicine at University of Ferrara, Italy
Research Team:
Marc Miravitlles
Helgo Magnussen
Dirkje S. Postma
David Price
Dermot Ryan
Nicolas Roche
Jennifer Quint
Therese Lapperre
Richard Costello
Juan José Soler-Cataluña
Caroline Gouder
Faisal Yunus
Bernardino Alcazar Navarrete
David Halpin
Akio Niimi

Status: Proposed Study, Seeking Funding
Support:
Registration:
Documents and Publications:
Protocol
Abstracts
Presentations
Final Publications
Additional Material

Zoe Mitchell

 

Leave a Reply

Your email address will not be published. Required fields are marked *